Probably, the most common alterations in leukaemia are those found in the RAS/MAPK pathway (50% of relapsed B-ALL, 15% of T-ALL and 50% of AML), such as KRAS, NRAS and PTPN11 mutations [28,31]. Here, KRAS is linked to acute lymphoblastic leukemia.